Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of biologically active compounds targeting central nervous system disorders and metabolic diseases. Its structure supports the construction of peptidomimetics and enzyme inhibitors, where the fluorinated pyrrolidine ring enhances metabolic stability and binding selectivity. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the constrained ring system and the presence of fluorine, which can improve bioavailability and membrane permeability. The tert-butyloxycarbonyl (Boc) protecting group allows for selective amine functionalization in multi-step syntheses, making it valuable in the preparation of complex drug candidates.